G protein-coupled receptor
5-HT1A receptor
5-hydroxytryptamine receptor 1A
- GeneHTR1A
- FamilySerotonin receptors
- Group5-HT1 receptors
The 5-HT1A receptor is one of the receptors for serotonin. Its gene was identified when the genomic clone G-21, found because it resembles the β-adrenergic receptor, turned out to encode it. The protein is a G protein-coupled receptor with seven transmembrane helices. It couples to the inhibitory G proteins Gi and Go, inhibits adenylyl cyclase and so lowers the level of cyclic AMP.1,2
The receptor does not work in the same way in every cell. Through the βγ subunits of its G proteins it opens G protein-gated inward rectifying potassium channels, which hyperpolarises the membrane, and in the raphe and its target regions it closes N-type voltage-dependent calcium channels, which lowers excitability. Both effects reduce the activity of the neuron. In serotonin neurons the receptor couples mainly to Gi3 and in hippocampal neurons mainly to Gi2. In developing and adult hippocampal neurons it activates the ERK1/2 kinase pathway, while in serotonin neurons it appears to inhibit it.2
The receptor is one of the most abundant serotonin receptors in the brain and occurs in two populations. Autoreceptors sit on the dendrites and cell bodies of serotonin neurons in the raphe nuclei, heteroreceptors on the neurons that receive the serotonin. In the rat brain the mRNA for the receptor is most abundant in the dorsal raphe nucleus, the septum, the hippocampus, the entorhinal cortex and the interpeduncular nucleus. Signals were also found in the olfactory bulb, the cerebral cortex, some thalamic and hypothalamic nuclei, several brainstem nuclei including all the other raphe nuclei, and the dorsal horn of the spinal cord. The distribution of the mRNA generally matches that of the binding sites, which suggests that the receptors sit mostly on the cell bodies and dendrites of the neurons that make them. In the forebrain the heteroreceptor is found on excitatory pyramidal neurons and on inhibitory interneurons.2,3
In post-mortem human brain, autoradiography with the antagonist WAY-100635 showed very dense binding in the hippocampus, the raphe nuclei and the neocortex. Binding in the neocortex was slightly lower than in the hippocampus and lay mainly in the superficial layers, with a faintly labelled band in the deeper layers. The amygdala, septum and claustrum showed low densities. Binding was very low in the basal ganglia (caudate nucleus and putamen), in the cerebellum and in the brainstem outside the raphe nuclei. Serotonin, buspirone, pindolol and 8-OH-DPAT displaced the radioligand. The carbon-11 form of the same compound is used for positron emission tomography (PET), and on human brain sections it gave a similar picture with lower resolution.4
On the serotonin neurons of the dorsal raphe in rats, the 5-HT1A agonists ipsapirone and LY 165163 suppressed firing, while two 5-HT1B compounds had only weak or irregular effects. This made 5-HT1A the most likely candidate for the autoreceptor on the cell bodies and dendrites of these neurons. The autoreceptors work as a brake on the serotonin system: serotonin released in the raphe activates them, and they inhibit the firing of the serotonin neurons. In midbrain slices of mice, 8-OH-DPAT reduced the electrically evoked release of serotonin and the antagonist WAY 100635 blocked this effect, while in slices of mice lacking the receptor 8-OH-DPAT had no effect.5,2,6
Several groups have made mice that lack the receptor. The animals grow normally, are viable and look healthy, and their brains show no obvious structural abnormality. Their tissue levels of serotonin and its metabolite 5-HIAA are normal, and so is the electrically evoked release of serotonin in midbrain slices. In hippocampal slices the 5-HT1B agonist CP93129 inhibited release more strongly in the knockouts than in wild-type mice, which suggests that the 5-HT1B autoreceptors on the nerve terminals might take over part of the work. Mice with one working copy of the gene have about half of the normal receptor density and in most behavioural tests lie between the two extremes.7,6,8
In tests of anxiety the knockout mice behave more fearfully. In an open field they explored the centre less and stayed close to the walls, in an elevated maze they spent less time in the open quadrants, and a novel object made them hesitate longer before approaching. In the elevated plus maze of a second group they entered the open arms less often and spent less time there. Home-cage activity was normal in that study, and in the study of Heisler the mutants moved as much as wild-type mice in the open field, so the effects are not a simple loss of movement. In the open field of the second group the knockouts did explore less overall, and only males showed the shift away from the centre, which the authors think may reflect a floor effect because the females were already very anxious. The effect was weaker in females in the other study. The antagonist WAY100635 lowered the time that wild-type mice spent in the centre of the open field, much as the knockout does, and had no effect in knockout mice. This suggests that the behaviour comes from the missing receptor itself and not from a developmental adaptation. The study of Parks reports the same tendency to avoid a novel and fearful environment.7,6,8
The mutants also behave like treated animals in tests used to screen antidepressants, which reduce immobility in these tests. In the tail suspension test the mutants of Heisler were immobile 85 percent less than wild-type mice. In the forced swim test of Ramboz, wild-type mice became more and more immobile during the session while the knockouts kept up the same level of activity. Ramboz suggested that the missing presynaptic receptors may act like the receptors that desensitise during long antidepressant treatment, and Heisler proposed a disinhibition of the serotonin neurons.7,6
Two compounds are the standard probes of the receptor, the agonist 8-OH-DPAT and the antagonist WAY 100635. 8-OH-DPAT is selective for the receptor, although it also activates the 5-HT7 receptor with ten times lower affinity. In rodents it causes hyperphagia, hypothermia and an anxiolytic response, and WAY 100635 blocks these effects. Mice without the receptor no longer respond to 8-OH-DPAT with a drop in body temperature.2,7
Buspirone, a partial agonist at the receptor, is approved as an anxiolytic. In the raphe nuclei it acts as a full agonist at the presynaptic receptors and inhibits the firing of serotonin neurons. It also blocks dopamine D2 autoreceptors, with an affinity about 15 times weaker than for the 5-HT1A receptor. In generalised anxiety disorder it has been reported to be as effective as diazepam, clorazepate, alprazolam and lorazepam. Unlike the benzodiazepines it is not linked to sedation, physical dependence, or cognitive and psychomotor impairment. Its side effects include dizziness, headaches, nausea, nervousness and paraesthesia.9,2
The ligands of the receptor do not tell the autoreceptors and heteroreceptors apart, so they can have opposing effects. In clinical studies both partial agonists and antagonists of the receptor have been reported to strengthen the effect of antidepressants. With long antidepressant treatment serotonin stays elevated, and the autoreceptor appears to desensitise more strongly than the heteroreceptor, which takes the brake off the serotonin neurons. Ligands that favour one population or one signalling pathway have recently been developed.2
Sources (9)
- Fargin et al. 1988Fargin A, Raymond JR, Lohse MJ, et al. (1988) The genomic clone G-21 which resembles a beta-adrenergic receptor sequence encodes the 5-HT1A receptor Nature
- Albert et al. 2019Albert PR, Vahid-Ansari F (2019) The 5-HT1A receptor: Signaling to behavior Biochimie
- Pompeiano et al. 1992Pompeiano M, Palacios JM, Mengod G (1992) Distribution and cellular localization of mRNA coding for 5-HT1A receptor in the rat brain: correlation with receptor binding J Neurosci
- Hall et al. 1997Hall H, Lundkvist C, Halldin C, et al. (1997) Autoradiographic localization of 5-HT1A receptors in the post-mortem human brain using [3H]WAY-100635 and [11C]way-100635 Brain Res
- Sprouse et al. 1987Sprouse JS, Aghajanian GK (1987) Electrophysiological responses of serotoninergic dorsal raphe neurons to 5-HT1A and 5-HT1B agonists Synapse
- Ramboz et al. 1998Ramboz S, Oosting R, Amara DA, et al. (1998) Serotonin receptor 1A knockout: an animal model of anxiety-related disorder Proc Natl Acad Sci U S A
- Heisler et al. 1998Heisler LK, Chu HM, Brennan TJ, et al. (1998) Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice Proc Natl Acad Sci U S A
- Parks et al. 1998Parks CL, Robinson PS, Sibille E, et al. (1998) Increased anxiety of mice lacking the serotonin1A receptor Proc Natl Acad Sci U S A
- Loane et al. 2012Loane C, Politis M (2012) Buspirone: what is it all about? Brain Res
Binding affinity (Kᵢ)
31 substances, 45 displayed values. Strongest first within each organism. The bar is pKᵢ on a log scale. Open a row to see the assay and every report behind the value.
Human
29 measurements
LSD1.3 nMEshleman et al. 2013 · 6 reports
- Assay
- cells expressing human 5-HT1A, [3H]8-OH-DPAT displacement
- Shown value from
- Eshleman et al. 2013, Table 5
- Range
- 1.2–9.5 nM in 6 reports
- Error
- ± 0.32 SEM, n = 10
This is the best-supported value. Other reports differ. 8 reports in all, 1.2–9.5 nM.
Sources and values behind the range, same assay family Report Value Where Halberstadt et al. 2020 9.5 nM Table 1 Jain et al. 2025 5.9 nM Table S4 Eshleman et al. 2018 1.2 nM Table 1 Janowsky et al. 2014 2.8 nM Table 1 Eshleman et al. 2014 2.5 nM Table 2 Eshleman et al. 2013 1.3 nM Table 5 5-MeO-DMT3.0 nMHalberstadt et al. 2012 · 4 reports
- Assay
- cloned human receptor; [3H]8-OH-DPAT competition binding (NIMH PDSP)
- Shown value from
- Halberstadt et al. 2012, Table 1
- Range
- 2.6–10 nM in 4 reports
- Error
- ± 0.20 SEM
Values depend on the assay, species or conditions, and each is valid only for its own. 5 reports in all, 1.9–10 nM.
Sources and values behind the range, same assay family Report Value Where Halberstadt et al. 2012 3.0 nM Table 1 Puigseslloses et al. 2024 2.6 nM Table 1 Jain et al. 2025 10 nM Table S4 Glatfelter et al. 2024 9.5 nM Supplement Figure S1 ETH-LAD3.5 nMJain et al. 2025
- Assay
- radioligand competition binding on crude membranes of transfected HEK293T cells (secondary binding assay, radioligand not stated in the paper)
- Shown value from
- Jain et al. 2025, Table S4
AL-LAD6.0 nMJain et al. 2025
- Assay
- radioligand competition binding on crude membranes of transfected HEK293T cells (secondary binding assay, radioligand not stated in the paper)
- Shown value from
- Jain et al. 2025, Table S4
Bufotenin8.3 nMJain et al. 2025
- Assay
- radioligand competition binding on crude membranes of transfected HEK293T cells (secondary binding assay, radioligand not stated in the paper)
- Shown value from
- Jain et al. 2025, Table S4
5-MeO-MiPT25 nMPuigseslloses et al. 2024 · 4 reports
- Assay
- human 5-HT1A receptor membranes; [3H]8-OH-DPAT competition binding
- Shown value from
- Puigseslloses et al. 2024, Table 1
- Range
- 25–143 nM in 4 reports
- Error
- ± 7.6 SD
This is the best-supported value. Other reports differ. 5 reports in all, 12–143 nM.
Sources and values behind the range, same assay family Report Value Where Rickli et al. 2016 58 nM Table 1 Kozell et al. 2023 143 nM Table 1 Puigseslloses et al. 2024 25 nM Table 1 Glatfelter et al. 2024 35 nM Supplement Figure S1 2C-P110 nMRickli et al. 2015
- Assay
- cloned human receptor (HEK293)
- Shown value from
- Rickli et al. 2015, Table 1
- Error
- ± 40 SD
Psilocin164 nMGlatfelter et al. 2022 · 5 reports
- Assay
- Transfected-cell radioligand binding at human 5-HT1A (UNC PDSP)
- Shown value from
- Glatfelter et al. 2022, Table 1
- Range
- 49–370 nM in 5 reports
Reported values disagree and no value is established. 6 reports in all, 49–370 nM.
Sources and values behind the range, same assay family Report Value Where Rickli et al. 2016 123 nM Table 1 Glatfelter et al. 2022 164 nM Table 1 Jain et al. 2025 370 nM Table S4 Dodd et al. 2023 123 nM, 49 nM Table 2 2C-I180 nMRickli et al. 2015
- Assay
- cloned human receptor (HEK293)
- Shown value from
- Rickli et al. 2015, Table 1
- Error
- ± 10 SD
Reported values disagree and no value is established. 2 reports in all, 180–970 nM.
2C-C190 nMRickli et al. 2015
- Assay
- cloned human receptor (HEK293)
- Shown value from
- Rickli et al. 2015, Table 1
- Error
- ± 10 SD
Reported values disagree and no value is established. 2 reports in all, 190–740 nM.
2C-B240 nMRickli et al. 2015 · 2 reports
- Assay
- cloned human receptor (HEK293)
- Shown value from
- Rickli et al. 2015, Table 1
- Range
- 240–241 nM in 2 reports
- Error
- ± 40 SD
Sources and values behind the range, same assay family Report Value Where Ray 2010 241 nM Table S2 (AllKiData) Rickli et al. 2015 240 nM Table 1 DMT356 nMKozell et al. 2023 · 5 reports
- Assay
- human 5-HT1A receptor in HEK cells; [3H]8-OH-DPAT competition binding
- Shown value from
- Kozell et al. 2023, Table 1
- Range
- 75–450 nM in 5 reports
- Error
- ± 34 SEM, n = 17
This is the best-supported value. Other reports differ. 5 reports in all, 75–450 nM.
Sources and values behind the range, same assay family Report Value Where Rickli et al. 2016 75 nM Table 1 Kozell et al. 2023 356 nM Table 1 Janowsky et al. 2014 450 nM Table 1 Jain et al. 2025 270 nM Table S4 Eshleman et al. 2014 400 nM Table 2 2C-E360 nMRickli et al. 2015 · 2 reports
- Assay
- cloned human receptor (HEK293)
- Shown value from
- Rickli et al. 2015, Table 1
- Range
- 307–360 nM in 2 reports
- Error
- ± 40 SD
Reported values disagree and no value is established. 3 reports in all, 307–1190 nM.
Sources and values behind the range, same assay family Report Value Where Ray 2010 307 nM Table S2 (AllKiData) Rickli et al. 2015 360 nM Table 1 2C-D440 nMRickli et al. 2015
- Assay
- cloned human receptor (HEK293)
- Shown value from
- Rickli et al. 2015, Table 1
- Error
- ± 10 SD
Reported values disagree and no value is established. 2 reports in all, 440–1630 nM.
4-HO-MET950 nMKozell et al. 2023 · 3 reports
- Assay
- human 5-HT1A receptor in HEK cells; [3H]8-OH-DPAT competition binding
- Shown value from
- Kozell et al. 2023, Table 1
- Range
- 135–950 nM in 3 reports
- Error
- ± 210 SEM, n = 3
Sources and values behind the range, same assay family Report Value Where Rickli et al. 2016 228 nM Table 1 Kozell et al. 2023 950 nM Table 1 Glatfelter et al. 2023 135 nM Table 2 ALD-521054 nMHalberstadt et al. 2020
- Assay
- cloned human 5-HT1A receptor; [3H]8-OH-DPAT competition
- Shown value from
- Halberstadt et al. 2020, Table 1
- Error
- ± 367 SEM, n = 5
6-APB1500 nMRickli et al. 2015
- Assay
- cloned human 5-HT1A receptor binding
- Shown value from
- Rickli et al. 2015, Table 3
- Error
- ± 200 SD
5-APB3300 nMRickli et al. 2015
- Assay
- cloned human 5-HT1A receptor binding
- Shown value from
- Rickli et al. 2015, Table 3
- Error
- ± 200 SD
DOM3660 nMEshleman et al. 2018 · 2 reports
- Assay
- recombinant human 5-HT1A receptor; [3H]8-OH-DPAT competition binding
- Shown value from
- Eshleman et al. 2018, Table 1
- Range
- 3660–7238 nM in 2 reports
- Error
- ± 470 SEM, n = 4
Sources and values behind the range, same assay family Report Value Where Luethi et al. 2026 7238 nM Table 1 Eshleman et al. 2018 3660 nM Table 1 4-FA4400 nMRickli et al. 2015
- Assay
- cloned human 5-HT1A receptor binding
- Shown value from
- Rickli et al. 2015, Table 3
- Error
- ± 800 SEM
Mescaline4600 nMRickli et al. 2015 · 2 reports
- Assay
- cloned human receptor (HEK293)
- Shown value from
- Rickli et al. 2015, Table 1
- Range
- 1841–4600 nM in 2 reports
- Error
- ± 400 SD
Sources and values behind the range, same assay family Report Value Where Ray 2010 1841 nM Table S2 (AllKiData) Rickli et al. 2015 4600 nM Table 1 MDA4900 nMRickli et al. 2015
- Assay
- cloned human 5-HT1A receptor binding
- Shown value from
- Rickli et al. 2015, Table 3
- Error
- ± 900 SD
4-FMA5000 nMRickli et al. 2015
- Assay
- cloned human 5-HT1A receptor binding
- Shown value from
- Rickli et al. 2015, Table 3
- Error
- ± 1900 SEM
α-PVP5200 nMRickli et al. 2015
- Assay
- cloned human 5-HT1A receptor binding
- Shown value from
- Rickli et al. 2015, Table 3
- Error
- ± 100 SEM
Psilocybin5284 nMGlatfelter et al. 2022 · 2 reports
- Assay
- Transfected-cell radioligand binding at human 5-HT1A (UNC PDSP)
- Shown value from
- Glatfelter et al. 2022, Table 1
- Range
- 5200–5284 nM in 2 reports
Sources and values behind the range, same assay family Report Value Where Glatfelter et al. 2022 5284 nM Table 1 Jain et al. 2025 5200 nM Table S4 Amphetamine6740 nMSimmler et al. 2013
- Assay
- Radioligand displacement binding in HEK293-cell membranes expressing human 5-HT1A
- Shown value from
- Simmler et al. 2013, Table 1
- Error
- ± 1380 SD
Methamphetamine8070 nMSimmler et al. 2013 · 3 reports
- Assay
- Radioligand displacement binding in HEK293-cell membranes expressing human 5-HT1A
- Shown value from
- Simmler et al. 2013, Table 1
- Range
- 5900–9700 nM in 3 reports
- Error
- ± 750 SD
Sources and values behind the range, same assay family Report Value Where Simmler et al. 2013 8070 nM Table 1 Eshleman et al. 2014 9700 nM Table 2 Eshleman et al. 2013 5900 nM Table 5
Mouse
5 measurements
5-MeO-DMT3.3 nMGlatfelter et al. 2024
- Assay
- mouse brain membranes, [3H]8-OH-DPAT competition binding at 5-HT1A
- Shown value from
- Glatfelter et al. 2024, Supplement Figure S11
5-MeO-MiPT27 nMGlatfelter et al. 2024
- Assay
- mouse brain membranes, [3H]8-OH-DPAT competition binding at 5-HT1A
- Shown value from
- Glatfelter et al. 2024, Supplement Figure S11
Cannabigerol (CBG)52 nMCascio et al. 2010
- Assay
- MF1 mouse whole-brain membranes; antagonism of 8-OH-DPAT stimulated [35S]GTPγS binding, Schild analysis (five concentrations, slope 1.1, apparent KB)
- Shown value from
- Cascio et al. 2010, Figure 8 legend (Schild plot)
Psilocin118 nMGlatfelter et al. 2022
- Assay
- C57BL/6J mouse brain membranes; [3H]8-OH-DPAT displacement
- Shown value from
- Glatfelter et al. 2022, Table 3
Psilocybin197 nMGlatfelter et al. 2022
- Assay
- C57BL/6J mouse brain membranes; [3H]8-OH-DPAT displacement
- Shown value from
- Glatfelter et al. 2022, Table 3
Pig
2 measurements
LSD2.5 nMPaulke et al. 2013
- Assay
- porcine receptor membrane binding assay; pKi converted to Ki
- Shown value from
- Paulke et al. 2013, Table 2
LSA10 nMPaulke et al. 2013
- Assay
- porcine receptor membrane binding assay; pKi converted to Ki
- Shown value from
- Paulke et al. 2013, Table 2
Rat
4 measurements
LSD5.0 nMPfaff et al. 1994
- Assay
- rat frontal cortex homogenate; [3H]8-OH-DPAT displacement
- Shown value from
- Pfaff et al. 1994, Table 4 (same values in Table 5)
5-MeO-DMT20 nMGlennon 1987
- Assay
- 5-HT1A site, [3H]-8-OH-DPAT (values compiled in a review, assays used rat cortex unless noted)
- Shown value from
- Glennon 1987, Table I
DMT130 nMDeliganis et al. 1991
- Assay
- Rat frontal cortex membranes, [3H]8-OH-DPAT competition without GTP
- Shown value from
- Deliganis et al. 1991, Results, Fig. 1A
- Error
- ± 6.0 SEM, n = 3
Psilocin190 nMDodd et al. 2023
- Assay
- 5-HT1A binding, compiled in a review (Table 2), original assay not restated
- Shown value from
- Dodd et al. 2023, Table 2
Unspecified
5 measurements
LSD2.6 nMGlennon 1987
- Assay
- 5-HT1A binding site (value for (+)-LSD quoted in the text of a review)
- Shown value from
- Glennon 1987, Text, section 5 (Ergolines)
5-MeO-DMT3.7 nMChen et al. 2023 · 4 reports
- Assay
- 5-HT1A receptor membranes (PerkinElmer 6110501400UA); [3H]8-OH-DPAT scintillation proximity competition binding
- Shown value from
- Chen et al. 2023, Table 2
- Range
- 1.9–10 nM in 4 reports
- Error
- ± 0.95 SD, n = 3
Sources and values behind the range, same assay family Report Value Where Chen et al. 2023 3.7 nM Table 2 Nelson 1991 1.9 nM, 7.8 nM, 10 nM Table 6, Table 6 (5-OMe-DMT) Bufotenin4.3 nMChen et al. 2023 · 2 reports
- Assay
- 5-HT1A receptor membranes (PerkinElmer 6110501400UA); [3H]8-OH-DPAT scintillation proximity competition binding
- Shown value from
- Chen et al. 2023, Table 2
- Range
- 4.3–25 nM in 2 reports
- Error
- ± 0.50 SD, n = 3
Sources and values behind the range, same assay family Report Value Where Chen et al. 2023 4.3 nM Table 2 Glennon 1987 25 nM Table III Psilocin84 nMChen et al. 2023 · 3 reports
- Assay
- 5-HT1A receptor membranes (PerkinElmer 6110501400UA); [3H]8-OH-DPAT scintillation proximity competition binding
- Shown value from
- Chen et al. 2023, Table 2
- Range
- 49–567 nM in 3 reports
- Error
- ± 26 SD, n = 3
Sources and values behind the range, same assay family Report Value Where Chen et al. 2023 84 nM Table 2 Plazas et al. 2023 49 nM Table 5 Dodd et al. 2023 567 nM Table 2 DMT87 nMChen et al. 2023 · 3 reports
- Assay
- 5-HT1A receptor membranes (PerkinElmer 6110501400UA); [3H]8-OH-DPAT scintillation proximity competition binding
- Shown value from
- Chen et al. 2023, Table 2
- Range
- 87–245 nM in 3 reports
- Error
- ± 15 SD, n = 3
Sources and values behind the range, same assay family Report Value Where Chen et al. 2023 87 nM Table 2 Keiser et al. 2009 183 nM Supplementary Table 4 Nelson 1991 245 nM Table 6
Functional potency (EC₅₀)
8 substances, 11 displayed values. Strongest first within each organism. Emax is shown where the paper reports it. Efficacy depends on the assay and its reference agonist.
Human
8 measurements
LSD1.3 nMEshleman et al. 2018 · 3 reports
- Assay
- recombinant human 5-HT1A receptor; [35S]GTPgammaS binding
- Shown value from
- Eshleman et al. 2018, Table 2
- Range
- 1.3–6.4 nM in 3 reports
- Error
- ± 0.46 SEM, n = 3
- Emax
- 93.2 ± 6.4%
This is the best-supported value. Other reports differ. 5 reports in all, 0.26–6.4 nM.
Sources and values behind the range, same assay family Report Value Where Eshleman et al. 2018 1.3 nM Table 2 Eshleman et al. 2014 6.4 nM Table 2 Eshleman et al. 2013 5.8 nM Table 6 5-MeO-DMT3.4 nMGlatfelter et al. 2024 · 2 reports
- Assay
- Transfected cells expressing human 5-HT1A; Galpha-oB dissociation BRET
- Shown value from
- Glatfelter et al. 2024, Figure 2A-B
- Range
- 3.4–26 nM in 2 reports
- Emax
- 115.0%
This is the best-supported value. Other reports differ. 5 reports in all, 3.4–791 nM.
Sources and values behind the range, same assay family Report Value Where Glatfelter et al. 2024 3.4 nM Figure 2A-B Warren et al. 2024 26 nM Main text, Structure-activity relationship of 5-MeO-tryptamines at 5-HT1A DMT210 nMKozell et al. 2023 · 3 reports
- Assay
- human 5-HT1A receptor in HEK cells; [35S]GTPgammaS binding
- Shown value from
- Kozell et al. 2023, Table 1
- Range
- 210–1490 nM in 3 reports
- Error
- ± 31 SEM, n = 18
- Emax
- 97.1 ± 2.4%
Values depend on the assay, species or conditions, and each is valid only for its own. 5 reports in all, 210–1585 nM.
Sources and values behind the range, same assay family Report Value Where Kozell et al. 2023 210 nM Table 1 Cameron et al. 2018 1490 nM Table 2 Eshleman et al. 2014 1490 nM Table 2 Bufotenin366 nMBlough et al. 2014
- Assay
- human 5-HT1A receptor in CHO-G16 cells; calcium mobilization
- Shown value from
- Blough et al. 2014, Table 1
- Error
- ± 67 SEM, n = 3
- Emax
- 95.0 ± 1.0%
Values depend on the assay, species or conditions, and each is valid only for its own. 2 reports in all, 9.3–366 nM.
5-MeO-MiPT610 nMKozell et al. 2023
- Assay
- human 5-HT1A receptor in HEK cells; [35S]GTPgammaS binding
- Shown value from
- Kozell et al. 2023, Table 1
- Error
- ± 210 SEM, n = 8
- Emax
- 109.1 ± 0.6%
Values depend on the assay, species or conditions, and each is valid only for its own. 4 reports in all, 37–610 nM.
Psilocin1084 nMWarren et al. 2024
- Assay
- cells expressing human 5-HT1A; Gi1 activation BRET
- Shown value from
- Warren et al. 2024, Supplementary Table 1
- Emax
- 88.7 ± 4.8%
4-HO-MET1390 nMKozell et al. 2023
- Assay
- human 5-HT1A receptor in HEK cells; [35S]GTPgammaS binding
- Shown value from
- Kozell et al. 2023, Table 1
- Error
- ± 490 SEM, n = 5
- Emax
- 89.8 ± 5.8%
2C-I4900 nMEshleman et al. 2014
- Assay
- HEK-h5-HT1A [35S]GTPγS functional assay
- Shown value from
- Eshleman et al. 2014, Table 2
- Error
- ± 2000 SEM
- Emax
- 102.1%
Mouse
2 measurements
5-MeO-DMT5.6 nMGlatfelter et al. 2024
- Assay
- Transfected cells expressing mouse 5-HT1A; Galpha-oB dissociation BRET
- Shown value from
- Glatfelter et al. 2024, Figure 2A-B
- Emax
- 107.0%
5-MeO-MiPT36 nMGlatfelter et al. 2024
- Assay
- Transfected cells expressing mouse 5-HT1A; Galpha-oB dissociation BRET
- Shown value from
- Glatfelter et al. 2024, Figure 2A-B
- Emax
- 101.0%
Rat
1 measurement
DMT4000 nMDeliganis et al. 1991 · 2 reports
- Assay
- Rat hippocampal membranes, inhibition of forskolin-stimulated adenylate cyclase
- Shown value from
- Deliganis et al. 1991, Results, Fig. 2
- Emax
- 30.0 ± 4.0%
Sources and values behind the range, same assay family Report Value Where Cameron et al. 2018 4000 nM Table 2 Deliganis et al. 1991 4000 nM Results, Fig. 2
Also reported to act here
Substances reported to act here, without a displayed value.
Values are published numbers in nM per organism. Different assays, species and receptor preparations are not directly interchangeable, and a value does not establish clinical potency or safety.